News & Updates
Filter by Specialty:
Brensocatib has no impact on COVID-19 clinical outcomes
Results of the STOP-COVID trial, presented at ERS 2022, showed no clinical outcome benefit with the dipeptidyl peptidase-1 (DPP-1) inhibitor brensocatib compared with placebo in patients hospitalized with COVID-19 in the UK.
Brensocatib has no impact on COVID-19 clinical outcomes
02 Oct 2022
Treatment-resistant depression imposes high healthcare utilization
Patients suffering from treatment-resistant depression (TRD) have higher healthcare resource utilization (HRU) associated with psychiatric services, reports a recent study.
Treatment-resistant depression imposes high healthcare utilization
02 Oct 2022
Pemafibrate superior to conventional fibrates in T2DM
Treatment with pemafibrate in patients with type 2 diabetes mellitus (T2DM) yields more favourable effects on lipid profile, as well renal function, as compared with conventional fibrates, a study has found.
Pemafibrate superior to conventional fibrates in T2DM
01 Oct 2022
Alcohol consumption ups risk of CVD, all-cause mortality in men
Recent evidence suggests that drinking alcoholic beverages is associated with cardiovascular diseases (CVD), including coronary artery disease (CAD), and all-cause mortality.
